US Physicalrapy Stock Target Price and Analyst Consensus

USPH Stock  USD 97.49  0.63  0.64%   
The current analyst and expert consensus on US Physicalrapy is Strong Buy, with 2 strong buy opinions. The current projected US Physicalrapy target price consensus is 124.75 with 6 analyst opinions. The most common way US Physicalrapy analysts use to provide recommendation to the public is financial statements analysis. Many experts also interview US Physicalrapy executives and customers to further validate their buy or sell advice. Note, the total number of analysts currently providing their opinion is not significant to determine adequate consensus on US Physicalrapy. We strongly encourage you to use your own analysis of US Physicalrapy to validate this buy or sell advice. US Physicalrapy buy-or-sell recommendation module provides average expert sentiment on the projected US Physicalrapy target price to derive its highest and lowest estimates based on its projected price volatility. Check out Macroaxis Advice on US Physicalrapy to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.
Lowest Forecast
113.52
Highest Forecast
138.47
Target Price
124.75
As of now, US Physicalrapy's Gross Profit is increasing as compared to previous years. The US Physicalrapy's current Pretax Profit Margin is estimated to increase to 0.09, while Operating Profit Margin is projected to decrease to 0.07. As of now, US Physicalrapy's Total Stockholder Equity is increasing as compared to previous years. The US Physicalrapy's current Property Plant And Equipment Net is estimated to increase to about 136 M, while Common Stock Shares Outstanding is projected to decrease to under 12.9 M.
  
It's important to approach US Physicalrapy's target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.

Steps to utilize US Physicalrapy price targets

US Physicalrapy's stock target price is an estimate of its future price, usually made by analysts. Using US Physicalrapy's target price to determine if it is a suitable investment can be done through the following steps:
  • Look at US Physicalrapy's target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
  • Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
  • Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
  • Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if US Physicalrapy's stock is likely to perform well.
  • Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Remember that stock target prices are just estimates and are subject to change. Therefore, using them as one factor in a larger investment strategy is essential rather than relying solely on them to make decisions.

Additional US Physicalrapy Value Projection Modules

Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of US Physicalrapy is a key component of US Physicalrapy valuation and have some predictive power on the future returns of a US Physicalrapy.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of US Physicalrapy's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
95.5997.3699.13
Details
Intrinsic
Valuation
LowRealHigh
87.74112.32114.09
Details
Naive
Forecast
LowNextHigh
91.9693.7395.51
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.460.560.67
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as US Physicalrapy. Your research has to be compared to or analyzed against US Physicalrapy's peers to derive any actionable benefits. When done correctly, US Physicalrapy's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in US Physicalrapy.

Trending Themes

If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment.
Baby Boomer Prospects Idea
Baby Boomer Prospects
Invested over 70 shares
Manufacturing Idea
Manufacturing
Invested over 40 shares
Automobiles and Trucks Idea
Automobiles and Trucks
Invested over 200 shares
Banking Idea
Banking
Invested over 30 shares
Momentum Idea
Momentum
Invested few shares
Driverless Cars Idea
Driverless Cars
Invested over 200 shares
Macroaxis Index Idea
Macroaxis Index
Invested few shares
When determining whether US Physicalrapy offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of US Physicalrapy's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Us Physicalrapy Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Us Physicalrapy Stock:
Check out Macroaxis Advice on US Physicalrapy to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon.
For more detail on how to invest in USPH Stock please use our How to Invest in US Physicalrapy guide.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for USPH Stock analysis

When running US Physicalrapy's price analysis, check to measure US Physicalrapy's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy US Physicalrapy is operating at the current time. Most of US Physicalrapy's value examination focuses on studying past and present price action to predict the probability of US Physicalrapy's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move US Physicalrapy's price. Additionally, you may evaluate how the addition of US Physicalrapy to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
The data published in US Physicalrapy's official financial statements usually reflect US Physicalrapy's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of US Physicalrapy. For example, before you start analyzing numbers published by USPH accountants, it's critical to develop an understanding of what US Physicalrapy's liquidity, profitability, and earnings quality are in the context of the Health Care Providers & Services space in which it operates.
Please note, the presentation of US Physicalrapy's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, US Physicalrapy's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in US Physicalrapy's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of US Physicalrapy. Please utilize our Beneish M Score to check the likelihood of US Physicalrapy's management manipulating its earnings.